DXC TECHNOLOGY CO (DXC) 28.15 +0.72 (+2.62%)
28.15 +0.72 (+2.62%)
US23355L1061 - Common Stock - After market: 28.15 0 (0%)
Fundamental Rating
Taking everything into account, DXC scores 4 out of 10 in our fundamental rating. DXC was compared to 154 industry peers in the IT Services industry. DXC has a medium profitability rating, but doesn't score so well on its financial health evaluation. DXC is valued quite cheap, while showing a decent growth score. This is a good combination!
Profitability
Profitability Rating
The Piotroski-F score of DXC is 9.00. This is a very strong score and indicates great health and profitability for DXC.
DXC's Return On Equity of 16.40% is in line with the rest of the industry. The industry average Return On Equity is 15.58%.
DXC's Return On Assets of 4.27% is worse than the rest of the industry. The industry average Return On Assets is 5.75%.
DXC's Profit Margin of 4.93% is worse than the rest of the industry. The industry average Profit Margin is 8.50%.
VS Industry
ROA (4.27%) VS Industry: 36% outperformed.
0.04
1,363.02
ROE (16.4%) VS Industry: 52% outperformed.
0.31
157.67
Profit Margin (4.93%) VS Industry: 32% outperformed.
0.12
59.05
Valuation
Valuation Rating
The Price/Earnings Ratio is 8.63, which indicates a very decent valuation of DXC.
Compared to an average industry Price/Earning Ratio of 19.53, DXC is valued rather cheaply. On top of this DXC is cheaper than 91% of the companies listed in the same industry.
The Forward Price/Earnings Ratio of 6.04 indicates a rather cheap valuation of DXC.
Compared to an average industry price book ratio of 3.05, DXC is valued rather cheaply
When comparing the Enterprise Value to EBITDA ratio of DXC to the average industry ratio of 12.42, DXC is valued rather cheaply. DXC is also cheaper than 96% of the companies listed in the same industry.
When comparing the current price to the book value of DXC, we can conclude it is valued correctly. It is trading at 1.39 times its book value.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
VS Industry
Price/Earnings (8.63) VS Industry: 91% outperformed.
2,040.18
0.02
Price/Book (1.39) VS Industry: 74% outperformed.
96.88
0.09
Enterprise Value/ EBITDA (2.63) VS Industry: 96% outperformed.
724.49
1.71
Growth
Growth Rating
DXC is expected to show quite a strong growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 14.63% yearly.
The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
DXC shows quite a strong growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 16.41% yearly.
The earnings per share for DXC have decreased by -1.51% in the last year.
Measured over the past 5 years, DXC shows a small growth in Earnings Per Share. The EPS has been growing by 2.40% on average per year.
DXC shows a decrease in Revenue. In the last year, the revenue decreased by -8.73%.
Based on estimates for the next 5 years, DXC will show a decrease in Revenue. The Revenue will decrease by -3.86% on average per year.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | 2.4% | -25.29% | -1.51% | 1.63% | 15.56% | 14.63% | N/A |
| Revenue | 16.41% | -7.8% | -8.73% | -11.73% | -6.34% | -3.86% | N/A |
Health
Health Rating
The Piotroski-F score of DXC is 9.00. This is a very strong score and indicates great health and profitability for DXC.
DXC has a Current Ratio of 1.14. This is a normal value and indicates that DXC is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.14 indicates that DXC should not have too much problems paying its short term obligations.
When comparing the Current Ratio of DXC to the average industry Current Ratio of 1.46, DXC is less able to pay its short term obligations than its industry peers.
When comparing the Quick Ratio of DXC to the average industry Current Ratio of 1.44, DXC is less able to pay its short term obligations than its industry peers.
When comparing the Debt to Equity Ratio of DXC to the average industry Debt to Equity Ratio of 0.32, DXC required more debt to finance its operations than its industry peers.
Based on the Altman-Z score of 1.14, we must say that DXC is in the distress zone and has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 1.96, DXC is in worse financial health than its industry peers.
VS Industry
Debt/Equity (0.8) VS Industry: 27% outperformed.
48.59
0.00
Quick Ratio (1.14) VS Industry: 34% outperformed.
0.04
11.05
Current Ratio (1.14) VS Industry: 33% outperformed.
0.04
11.05
Altman-Z (1.14) VS Industry: 36% outperformed.
-270.35
24.56
Dividend
Dividend Rating
DXC does not give a dividend.
DXC TECHNOLOGY CO28.15
NYSE:DXC (2/7/2023, 7:04:00 PM)+0.72 (+2.62%)
| GICS Sector | Information Technology | ||
| GICS IndustryGroup | Software & Services | ||
| GICS Industry | IT Services | ||
| Earnings (Last) | 02-01 2023-02-01/amc | Earnings (Next) | 05-23 2023-05-23/amc |
| Inst Owners | 89.35% | Inst Owner Change | -1.35% |
| Ins Owners | 0.71% | Ins Owner Change | -5.22% |
| Market Cap | 6.41B | Analysts | 69.47 |
| Price Target | 34.52 (22.63%) | ||
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
| Dividend Growth(5Y) | N/A | DP | 0% |
| Div Incr Years | 1 | Div Non Decr Years | 1 |
| Ex-Date | N/A | ||
| EPS beat(2) | 1 | Avg EPS beat(2) | -3.98% |
| Min EPS beat(2) | -9.44% | Max EPS beat(2) | 1.49% |
| EPS beat(4) | 1 | Avg EPS beat(4) | -6.11% |
| Min EPS beat(4) | -16.13% | Max EPS beat(4) | 1.49% |
| Revenue beat(2) | N/A | Avg Revenue beat(2) | -0.98% |
| Min Revenue beat(2) | -1.41% | Max Revenue beat(2) | -0.56% |
| Revenue beat(4) | N/A | Avg Revenue beat(4) | -1.7% |
| Min Revenue beat(4) | -3.68% | Max Revenue beat(4) | -0.56% |
| PT rev (1m) | -0.94% | PT rev (3m) | -0.45% |
| EPS NQ rev (1m) | N/A | EPS NQ rev (3m) | N/A |
| EPS NY rev (1m) | 0% | EPS NY rev (3m) | -0.76% |
| Revenue NQ rev (1m) | N/A | Revenue NQ rev (3m) | N/A |
| Revenue NY rev (1m) | 0% | Revenue NY rev (3m) | -0.73% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.63 | ||
| Fwd PE | 6.04 | ||
| P/S | 0.42 | ||
| P/FCF | 9.91 | ||
| P/OCF | 4.78 | ||
| P/B | 1.39 | ||
| P/tB | 5.48 | ||
| EV/EBITDA | 2.63 |
| EPS(TTM) | 3.26 | EY | 11.58% |
| EPS(NY) | 4.66 | Fwd EY | 16.56% |
| FCF(TTM) | 2.84 | FCFY | 10.09% |
| OCF(TTM) | 5.89 | OCFY | 20.92% |
| SpS | 67.51 | BVpS | 20.27 |
| TBVpS | 5.13 | PEG (NY) | 5.28 |
| PEG (5Y) | 3.6 | ||
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 16.4% | ||
| ROIC | 9.33% | ||
| ROICexc | 11.45% | ||
| ROICexgc | 17.49% | ||
| OM | 9.41% | ||
| PM | 4.93% | ||
| GM | 21.63% |
| ROICexgc(3y) | N/A | ROICexcg growth 3Y | -27.9% |
| ROICexcg growth 5Y | 35.71% | ROICexc(3y) | N/A |
| ROICexc growth 3Y | -0.76% | ROICexc growth 5Y | 59.47% |
| OM growth 3Y | -8.59% | OM growth 5Y | 59.7% |
| PM growth 3Y | -10.01% | PM growth 5Y | N/A |
| GM growth 3Y | -7.67% | GM growth 5Y | -4.07% |
| F-Score | 9 | Asset Turnover | 0.87 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.8 | ||
| Debt/FCF | 7 | ||
| Debt/EBITDA | 1.46 | ||
| Cap/Depr | 42.09% | ||
| Profit Quality | 85.47% | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 1.14 |
| F-Score | 9 | WACC | 9.1% |
| ROIC/WACC | 1.92 | Cap/Depr(3y) | 42.24% |
| Cap/Depr(5y) | 42.33% | Profit Quality(3y) | N/A |
| Profit Quality(5y) | N/A | ||
| EPS 1Y | -1.51% | EPS 3Y | -25.29% |
| EPS 5Y | 2.4% | EPS growth Q2Q | -15.73% |
| EPS Next Y | 1.63% | EPS Next 2Y | 15.56% |
| EPS Next 3Y | 14.63% | EPS Next 5Y | N/A |
| Revenue growth 1Y | -8.73% | Revenue growth 3Y | -7.8% |
| Revenue growth 5Y | 16.41% | Revenue growth Q2Q | -11.45% |
| Revenue Next Year | -11.73% | Revenue Next 2Y | -6.34% |
| Revenue Next 3Y | -3.86% | Revenue Next 5Y | N/A |
| EBIT growth 1Y | 1202.7% | EBIT growth 3Y | -15.72% |
| EBIT growth 5Y | 85.92% | EBIT Next Year | 64.51% |
| EBIT Next 3Y | 21.34% | EBIT Next 5Y | N/A |
| FCF growth 1Y | 13.71% | FCF growth 3Y | -1.47% |
| FCF growth 5Y | 43.21% | OCF growth 1Y | -0.89% |
| OCF growth 3Y | -4.5% | OCF growth 5Y | 20.2% |
Fundamental Stock Screener Links
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA